↓ Skip to main content

Proteolysis targeting chimeras (PROTACs) in cancer therapy

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, September 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
2 news outlets
twitter
2 X users
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
103 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Proteolysis targeting chimeras (PROTACs) in cancer therapy
Published in
Journal of Experimental & Clinical Cancer Research, September 2020
DOI 10.1186/s13046-020-01672-1
Pubmed ID
Authors

Alberto Ocaña, Atanasio Pandiella

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 103 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 103 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 12%
Student > Master 10 10%
Student > Ph. D. Student 7 7%
Student > Bachelor 6 6%
Other 6 6%
Other 13 13%
Unknown 49 48%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 17 17%
Chemistry 14 14%
Agricultural and Biological Sciences 8 8%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Medicine and Dentistry 3 3%
Other 4 4%
Unknown 51 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 December 2022.
All research outputs
#1,837,018
of 25,387,668 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#63
of 2,382 outputs
Outputs of similar age
#49,255
of 426,757 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#3
of 78 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,382 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,757 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 78 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.